Accéder au contenu
Merck
  • Single-site chemical modification at C10 of the baccatin III core of paclitaxel and Taxol C reduces P-glycoprotein interactions in bovine brain microvessel endothelial cells.

Single-site chemical modification at C10 of the baccatin III core of paclitaxel and Taxol C reduces P-glycoprotein interactions in bovine brain microvessel endothelial cells.

Bioorganic & medicinal chemistry letters (2005-11-18)
Jared T Spletstoser, Brandon J Turunen, Kelly Desino, Antonie Rice, Apurba Datta, Dinah Dutta, Jacquelyn K Huff, Richard H Himes, Kenneth L Audus, Anna Seelig, Gunda I Georg
RÉSUMÉ

A single-site modification of paclitaxel analogs at the C10 position on the baccatin III core that reduces interaction with P-glycoprotein in bovine brain microvessel endothelial cells is described. Modification and derivatization of the C10 position were carried out using a substrate controlled hydride addition to a key C9 and C10 diketone intermediate. The analogs were tested for tubulin assembly and cytotoxicity, and were shown to retain potency similar to paclitaxel. P-glycoprotein interaction was examined using a rhodamine assay and it was found that simple hydrolysis or epimerization of the C10 acetate of paclitaxel and Taxol C can reduce interaction with the P-glycoprotein transporter that may allow for increased permeation of taxanes into the brain.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Baccatin III, ≥95% (HPLC)